The Largest Personal Injury Firm in Texas. Serving Clients Nationwide.
Corpus Christi 361-985-0600 San Antonio 210-656-1000 Nationwide Toll Free 888-314-9945
Contact us 24/7

Patient Has Meningitis Relapse in Tennessee During Outbreak

View all
David Turnbull4 years ago

The Washington Post has reported that a patient who was being treated in response to the New England Compounding Center meningitis outbreak has relapsed as the bill set to regulate such companies has been stalled by the government shutdown.

Patient Has Meningitis Relapse in Tennessee During Outbreak

  • A patient was admitted to Saint Thomas West Hospital on October 3rd related to a relapse from illness involving a nationwide meningitis outbreak from tainted steroids compounded at the New England Compounding Center in Massachusetts. 
  • Tennessee saw a larger proportion of the 750 affected people nationwide, with 2,000 vials of compounded steroids being sent to St. Thomas Outpatient Neurosurgery Center in Nashville. 
  • According to the CDC, the outbreak has been linked to cases in 20 states and has resulted in the deaths of 64 patients.

Bill Regulating Compounding Pharmacies Stalled due to Govt. Shutdown

  • Presently the U.S. Senate is awaiting a vote on the Drug Quality and Security Act, which if passed, would set national standards for pharmaceutical tracking and monitoring during the distribution process from compounding centers.
  • Should the bill pass, the U.S. Food and Drug Administration would be responsible for regulating larger compounding pharmacies which distribute their products accross state lines, a role currently left to state departments as it is believed that the states lack the necessary resources to investigate such large entities.
  • Congress hopes the FDA will help reduce outbreaks like that of the New England Compounding Center and a more recent outbreak in which patients suffered blood infections following treatment with tainted IV bags from Specialty Compounding near Austin, Texas.
  • The bill was moved quickly through the House of Representatives and was expected to face little resistance in the Senate as both branches of Congress had already agreed on the regulations laid out in the bill; however, with a government shutdown in effect, the bill is currently stalled.
Contact an Experienced Product Liability Attorney

Thomas J. Henry are leaders in the area of drug and product liability litigation. Our Defective Drug and Products Division have extensive knowledge and resources in order to represent our clients efficiently and aggressively. The Defective Drug and Products Division represent a multitude of people who are battling against manufacturers of medical devices and/ or defective pharmaceuticals.

If you or a loved one have been injured by or have developed serious side-effects from the use of defective medications or pharmaceuticals, contact Thomas J. Henry immediately. We represent clients/victims all over the country. We are available 24/7, nights and weekends.


Contact Us for a FREE Case Review

888-314-9945 •